# 4D Molecular (FDMT) — Overview

FDMT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/fdmt

## Price

Last close $12.87 on Oct 15, 2026. 52-week range $7.19 – $16.76.

## Company profile

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $92.0M |
| Revenue (quarter) | $3.8M |
| Revenue growth (year over year) | 25106.67% |
| Gross profit (trailing twelve months) | $92.0M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$179.2M |
| Net income (quarter) | −$72.9M |
| Net income growth (year over year) | -33.44% |
| Net margin | -194.74% |
| Return on equity | -43.25% |
| EPS (trailing twelve months) | −$2.63 |
| Book value per share | $7.38 |
| P/E (trailing twelve months) | — |
| Price to book | 1.7 |
| Debt to assets | 17.25% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is 4D Molecular (FDMT) profitable?

No. 4D Molecular reported a net loss of $179.2M over the trailing twelve months.

### How much revenue does 4D Molecular (FDMT) make?

4D Molecular generated $92.0M in revenue over the trailing twelve months, up 25106.67% year over year.

### How do I buy stock in 4D Molecular (FDMT)?

FDMT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).